Cargando…

In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease

OBJECTIVE: The Systemic Synuclein Sampling Study (S4) measured α-synuclein in multiple tissues and biofluids within the same patients with Parkinson disease (PD) vs healthy controls (HCs). METHODS: S4 was a 6-site cross-sectional observational study of participants with early, moderate, or advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chahine, Lana M., Beach, Thomas G., Brumm, Michael C., Adler, Charles H., Coffey, Christopher S., Mosovsky, Sherri, Caspell-Garcia, Chelsea, Serrano, Geidy E., Munoz, David G., White, Charles L., Crary, John F., Jennings, Danna, Taylor, Peggy, Foroud, Tatiana, Arnedo, Vanessa, Kopil, Catherine M., Riley, Lindsey, Dave, Kuldip D., Mollenhauer, Brit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Null Hypothesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538226/ https://www.ncbi.nlm.nih.gov/pubmed/32747521 http://dx.doi.org/10.1212/WNL.0000000000010404

Ejemplares similares

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)
por: Chahine, Lana M., et al.
Publicado: (2018)

Repetitive TMS does not improve cognition in patients with TBI: A randomized double-blind trial
por: Neville, Iuri Santana, et al.
Publicado: (2019)

A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy
por: Lochmüller, Hanns, et al.
Publicado: (2019)

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019)

Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies
por: Todd, Joshua J., et al.
Publicado: (2020)

Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial
por: Elkind, Mitchell S.V., et al.
Publicado: (2020)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

No Significant Effects of Cellphone Electromagnetic Radiation on Mice Memory or Anxiety: Some Mixed Effects on Traumatic Brain Injured Mice
por: Qubty, Doaa, et al.
Publicado: (2021)

Intermittent Hypoxia Induces Greater Functional Breathing Motor Recovery as a Fixed Rather Than Varied Duration Treatment after Cervical Spinal Cord Injury in Rats
por: Silverstein, Aaron L., et al.
Publicado: (2021)

Activation of the Protein Kinase R–Like Endoplasmic Reticulum Kinase (PERK) Pathway of the Unfolded Protein Response after Experimental Traumatic Brain Injury and Treatment with a PERK Inhibitor
por: Brady, Rhys D., et al.
Publicado: (2021)

Insulin-Like Growth Factor-2 (IGF-2) Does Not Improve Memory in the Chronic Stage of Traumatic Brain Injury in Rodents
por: Redell, John B., et al.
Publicado: (2021)

Relationship between Sport-Related Concussion and Sleep Based on Self-Report and Commercial Actigraph Measurement
por: Considine, Ciaran M., et al.
Publicado: (2021)

White Matter Hyperintensities Are Not Related to Symptomatology or Cognitive Functioning in Service Members with a Remote History of Traumatic Brain Injury
por: Lippa, Sara M., et al.
Publicado: (2021)

Lymphocytes Are Not Required for Neurogenic Heterotopic Ossification Development after Spinal Cord Injury
por: Alexander, Kylie A., et al.
Publicado: (2022)

Solar Panels and Political Attitudes
por: Umit, Resul
Publicado: (2021)

Direct Ryanodine Receptor-2 Knockout in Primary Afferent Fibers Modestly Affects Neurological Recovery after Contusive Spinal Cord Injury
por: Orem, Ben C., et al.
Publicado: (2022)

Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study
por: Rogatzki, Matthew J., et al.
Publicado: (2023)

Brain Spectroscopy Analysis in Retired Soccer Players With Chronic Exposure to Mild Traumatic Brain Injuries
por: Resende, Lucas Lopes, et al.
Publicado: (2023)

Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
por: Chahine, Lana M., et al.
Publicado: (2023)

Status of Current Biofluid Biomarkers in Parkinson's Disease
por: Mollenhauer, Brit
Publicado: (2023)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
por: Signaevsky, Maxim, et al.
Publicado: (2022)

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
por: Eidson, Lori N., et al.
Publicado: (2017)

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2022)

The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial
por: Schulte, MHJ, et al.
Publicado: (2017)

Probabilistic reversal learning under acute tryptophan depletion in healthy humans: a conventional analysis
por: Kanen, Jonathan W, et al.
Publicado: (2020)

Muscimol-induced inactivation of the anterior cingulate cortex does not impair trace fear conditioning in the rat
por: Pezze, Marie A, et al.
Publicado: (2020)

Neural effects of a single dose of fluoxetine on resting-state functional connectivity in adolescent depression
por: Capitão, Liliana P, et al.
Publicado: (2020)

Hemochromatosis, Iron Overload–Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare
por: Julián-Serrano, Sachelly, et al.
Publicado: (2021)

Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
por: Cohen, Isaac Victor, et al.
Publicado: (2021)

Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis
por: Park, Hanla A., et al.
Publicado: (2022)

Longitudinal Analyses of Cerebrospinal Fluid α-Synuclein in Prodromal and Early Parkinson’s Disease
por: Mollenhauer, Brit, et al.
Publicado: (2019)

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
por: Brumm, Michael C., et al.
Publicado: (2023)

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight
por: Al-Azzani, Mohammed, et al.
Publicado: (2022)

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
por: Marek, Kenneth, et al.
Publicado: (2018)

Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
por: Chahine, Lana M., et al.
Publicado: (2019)

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
por: Merchant, Kalpana M., et al.
Publicado: (2023)

A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations
por: Mollenhauer, Brit, et al.
Publicado: (2017)

Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease
por: Dashtipour, Khashayar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3r1svgim56rtpsm7jme0aood41